FDA Releases Draft Revised Guidance on Waivers for Animal Drugs in Soluble Powder Oral Dosage Form Products and Type A Medicated Articles

Summary

The FDA is releasing a draft revised guidance for industry regarding waivers for animal drugs in soluble powder oral dosage form products and Type A medicated articles. This guidance outlines how the FDA will evaluate requests for waiving the requirement for bioequivalence data.